what is Erooms Law

Eroom's Law, also known as Moore's Law spelled backward, is a phrase coined by pharmaceutical researchers to describe the phenomenon of declining productivity in the development of new drugs. The term "Eroom's Law" is derived from "Moore's Law," which refers to the observation made by Gordon Moore, co-founder of Intel, that the number of transistors on a microchip doubles approximately every two years.

Eroom's Law suggests that despite advancements in technology and increased investment in research and development, the number of new drugs approved per billion dollars spent on R&D has been steadily declining over time. This trend implies that the cost of developing new drugs is increasing while the rate of successful drug discovery is decreasing.

The term "Eroom's Law" was introduced in 2012 by researchers Jack W. Scannell, Alex Blanckley, Helen Boldon, and Brian Warrington in an article published in the journal Nature Reviews Drug Discovery. It highlights the challenges faced by the pharmaceutical industry, including rising costs, lengthy development timelines, and a higher rate of drug candidate failures in clinical trials.